Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Fda Inspections
  6. /
  7. Shair Laboratories, Inc.
FDA Inspection
•Shair Laboratories, Inc.•March 22, 2011

Shair Laboratories, Inc. – FDA Inspection, Mar 22, 2011

Record Details

This FDA Inspection record concerns Shair Laboratories, Inc., with an inspection on March 22, 2011, issued by the Center for Drug Evaluation and Research, covering drugs.

Company
Shair Laboratories, Inc.
Inspection Date
March 22, 2011
Product Type
Drugs
Office
Center for Drug Evaluation and Research
View Company Profile

ID · c53e2976-581f-47b2-a29c-fb6729532dec

Inspection Facts

Voluntary Action Indicated (VAI)

Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.

Inspection number
711505
FDA center
Human Drugs
Project area
Unapproved and Misbranded Drugs

FDA Citations

27
  1. 21 CFR 211.103Actual vs. theoretical yields not determined
  2. 21 CFR 211.188Prepared for each batch, include complete information
  3. 21 CFR 211.142(a)Quarantine - actual practice
  4. 21 CFR 211.137(a)Expiration date lacking
  5. 21 CFR 211.25(a)Training--operations, GMPs, written procedures
  6. 21 CFR 211.110(c)In-process materials characteristics testing
  7. 21 CFR 211.122(b)Labeling and packaging improperly approved/released
  8. 21 CFR 211.198(a)Complaint Handling Procedure
  9. 21 CFR 211.34Consultant Records
  10. 21 CFR 211.170(b)(1)Retention time of reserve samples, in general

Showing 10 of 27 citations.

Full citation text and observation details available on the Dashboard.

Other FDA inspections of Shair Laboratories, Inc.

4
DateClassificationOfficeProject area
April 27, 2017NAICenter for Food Safety and Applied NutritionColors and Cosmetics Technology
April 27, 2017NAICenter for Food Safety and Applied NutritionColors and Cosmetics Technology
June 1, 2011NAICenter for Drug Evaluation and ResearchUnapproved and Misbranded Drugs
February 12, 2010OAICenter for Drug Evaluation and ResearchUnapproved and Misbranded Drugs
Other documents for Shair Laboratories, Inc.
  • FDA Inspection 1013212 - 2017-04-27
  • FDA Inspection 1012931 - 2017-04-27
  • FDA Inspection 737843 - 2011-06-01
  • FDA Inspection 642144 - 2010-02-12

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Shair Laboratories, Inc.
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.